| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e51cb26ccb205995a528a692a209ac4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0081 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-10 |
| filingDate |
2010-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a94a17530853d6f6e2a7cf14eef32df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bdc7d1bae7b8064d25efd294abfa344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb64510dd4bc2f809c47c08424559a6a |
| publicationDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2011017003-A |
| titleOfInvention |
Heparin-like compounds, their manufacture and use to inhibit arterial thrombosis due to vascular injury and intervention |
| abstract |
A heparin-like compound that inhibits collagen-induced platelet aggregation and uses in the prophylactic treatment of arterial thrombosis by vascular or capillary injury and intervention. The heparin-like compound comprises multiple heparin or heparin-like glycosaminoglycan and the multiple heparin or heparin-like glycosaminoglycan or low molecular weight heparin linked directly or via a spacer / linker to the spherical core molecule. It has a high coupling density of negatively charged heparin or heparin-like glycosaminoglycan molecules present in proteoglycans including heparin-like glycosaminoglycans. The heparin-like compound is obtained by tissue extraction or cell culture from mammalian mast cells and is a preparation for local or topical application in prophylactic treatment of arterial thrombosis and its sequelae, Useful for making means and devices. [Selection figure] None |
| priorityDate |
1997-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |